60 Degrees Pharmaceuticals Announces First Quarter 2024 Results
15 mai 2024 13h45 HE
|
Sixty Degrees Pharmaceuticals
SXTP posts Q1 2024 net product revenues increase of 515% year-over-year to $105.7 thousand in a Q1 earnings report released today.
60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required
02 mai 2024 07h59 HE
|
Sixty Degrees Pharmaceuticals
SXTP received FDA comments on tafenoquine-babesiosis trial protocol; no major changes are needed. Trial planning and execution to proceed as planned.
AssistRx Launches Advanced Access Anywhere to Expedite Access and Automate Enrollment at the Point of Pharmacy Claim
25 avr. 2024 08h00 HE
|
AssistRx
Advanced Access Anywhere expands on AssistRx's digital intake strategies to automate enrollment at the point of pharmacy claim.
AssistRx Earns URAC Reaccreditation in Mail Service Pharmacy
16 avr. 2024 10h00 HE
|
AssistRx
AssistRx, the advanced therapy initiation and patient solutions provider, has again earned the URAC accreditation for Mail Service Pharmacy.
60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis
03 avr. 2024 07h58 HE
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease.
Crossject reports financial results and business highlights for first half of 2023
26 sept. 2023 11h35 HE
|
CROSSJECT
Press Release Crossject reports financial results and business highlights for first half of 2023 Strong progress in bringing drugs for use in emergency situations towards the market ...
Crossject présente ses résultats financiers et faits marquants du premier semestre 2023
26 sept. 2023 11h35 HE
|
CROSSJECT
Communiqué de presse Crossject présente ses résultats financiers et faits marquants du premier semestre 2023 De solides avancées vers la mise sur le marché de médicaments dédiés aux situations...
AssistRx Launches Advanced Gateway to Address Increasing Demands of Patient Support Programs
20 juin 2023 09h00 HE
|
AssistRx
ORLANDO, Fla., June 20, 2023 (GLOBE NEWSWIRE) -- AssistRx, the advanced therapy initiation and patient solutions provider, recently launched Advanced Gateway, a first-to-market single API...
AssistRx Debuts New Website following Record Growth and Enterprise Expansion
14 avr. 2020 10h00 HE
|
AssistRx
ORLANDO, Fla., April 14, 2020 (GLOBE NEWSWIRE) -- AssistRx, the intelligent therapy initiation and patient support solutions provider, today announced the launch of a new website to reflect the...
Albertsons Companies Specialty Care Joins AssistRx Specialty Pharmacy Network
17 déc. 2019 10h00 HE
|
AssistRx
ORLANDO, Fla. , Dec. 17, 2019 (GLOBE NEWSWIRE) -- Albertsons Companies Specialty Care is now using the AssistRx technology platform to give patients and providers quicker access to their specialty...